Let’s
Outdo
Cancer
A world where people with cancer live better and longer lives—that’s our vision. We are accelerating breakthrough medicines that bring new hope to patients everywhere.
Cancer updates & breakthroughs
Patrick Dempsey joins efforts to “Change the Odds” against cancer
We have partnered with cancer community advocate and actor Patrick Dempsey to spotlight the impact of cancer in rural communities.
Cancer is rising, but the risk of death is dropping
The American Cancer Society reports lower overall cancer death rates in 2024, yet incidence is increasing for many common cancers, including 6 of the top 10.
Leading the future of blood cancer research
Find out what happened at the American Society of Hematology Annual Meeting & Exposition 2024.
Driving breast cancer innovations forward
AI and real-world evidence: Read highlights from the San Antonio Breast Cancer Symposium 2024.
Advancing
science
Dive into our research and how we’re making strides against cancer.
Explore our expertise in major cancer types
Breast cancer
We’re focused on redefining what’s possible in breast cancer care.
Lung, prostate, bladder, colorectal, and more
Explore each of the cancer types we’re focused on.
Building on a legacy of breakthroughs
With a history of bringing life-changing medicines to the world, Pfizer is constantly gaining ground against cancer. Today, approximately 40% of our research and development (R&D) investment is focused on advancing innovative cancer therapies.
Explore our milestones.
2024
New phase 3 clinical trials started for new potential medicines in lung, breast, and prostate cancer
2024
Clinical trial results in ALK (anaplastic lymphoma kinase) -positive non-small cell lung cancer (NSCLC), representing a potential advancement in lung cancer treatment
2023
Seagen becomes part of Pfizer, bringing world-leading ADC technology to Pfizer and doubling the number of clinical trials in cancer
2023
Bispecific antibody medicine that harnesses the body’s immune system to treat advanced multiple myeloma is approved
2023
Groundbreaking clinical trial results of a combination antibody-drug conjugate (ADC) and immunotherapy demonstrate the potential to change how advanced bladder cancer is treated
2023
A medicine that inhibits the poly (ADP-ribose) polymerase (PARP) protein on cancer cells combined with existing medicines to treat an advanced form of prostate cancer is approved
2020
The first medicine that precisely targets colorectal cancer (CRC) cells that are positive for a specific gene mutation that plays a critical role in CRC is approved
2018
ALK-positive lung cancer medicine, which overcomes common mutations that are known to stop other medicines from working, is approved
2015
Innovative medicine for people with metastatic breast cancer (mBC) is approved, marking the first advancement in mBC in more than 10 years
2011
First-ever medicine to inhibit the abnormal ALK proteins in lung cancer is approved
Advancing treatments
together
Tomorrow’s cancer treatments are being developed in today’s clinical trials. When you participate, you’re making it possible to bring breakthrough medicines to people living with cancer.
Stories of
strength
Discover the inspiring stories
of real people living with cancer.
video_id: 6365867268112
Change the Odds
When it comes to cancer, the odds seem stacked against certain communities. At Pfizer, we are proud to partner with the American Cancer Society on a new program to help change that.
video_id: 6365868327112
Lynce’s story | Multiple myeloma
How her journey led to finding her voice and empowering others living with multiple myeloma.
video_id: 6365904116112
Tom's story | Prostate cancer
How Tom has become an advocate for the prostate cancer community, emphasizing the importance of continued patient education and living life to its fullest.